Smith Karen L.
Director at AUPH; Director at ACCELERON PHARMA INC
- Sold, on record
- $2.9M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Nov 11, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- AUPHAurinia Pharmaceuticals Inc.Director
- ACCELERON PHARMA INCDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- ACCELERON PHARMA INC20,789 shares
- AUPH5,241 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ACCELERON PHARMA INCUnusualApr 1 2021
Sold 8,925 shares at $136.47 ($1.2M)
Smith Karen L., Director
Sold 66.2% of holdings ($1.8M position)4,561 shares leftFirst sale on recordFiling
- 2 Form 4 sale ACCELERON PHARMA INCUnusualApr 5 +4 days
Sold 11,864 shares at $140.19 ($1.7M)
Smith Karen L., Director
Sold 88% of holdings ($1.9M position)1,622 shares leftFiling
- 3 Form 4 sale AUPHUnusualNov 11 +1316 days
Sold 5,241 shares at $8.43 ($44k)
Smith Karen L., Director
No 10b5-1 planSold 29.3% of holdings ($151k position)12,672 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | AUPH | Director | Form 4 sale | 5,241 | $44k | 29.3% | Unusual | SEC |
| Apr 5, 2021 | ACCELERON PHARMA INC | Director | Form 4 sale | 11,864 | $1.7M | 88.0% | Unusual | SEC |
| Apr 1, 2021 | ACCELERON PHARMA INC | Director | Form 4 sale | 8,925 | $1.2M | 66.2% | Unusual | SEC |